VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)
CUSIP: 928661107
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 129,251,202
- Total 13F shares
- 23,985,160
- Share change
- +2,976,577
- Total reported value
- $18,228,005
- Price per share
- $0.76
- Number of holders
- 28
- Value change
- +$2,275,044
- Number of buys
- 15
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 928661107?
CUSIP 928661107 identifies VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 928661107:
Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Eight Corp Ltd |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
24,030,664
mixed-class rows
|
$20,785,825 | — | 02 Jan 2024 | |
| Lagoda Investment Management, L.P. |
13F
|
Company |
7.9%
|
10,194,000
|
$5,811,599 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
6.3%
|
8,206,430
|
$4,678,486 | — | 31 Mar 2025 | |
| Martin Charles Faulkes |
3/4/5
|
Executive Director, Director |
—
class O/S missing
|
2,096,207
|
$1,739,852 | — | 24 Jan 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
761,951
|
$434,497 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
706,060
|
$402,454 | — | 31 Mar 2025 | |
| Edward Futcher |
3/4/5
|
Director |
—
class O/S missing
|
436,436
|
$362,242 | — | 24 Jan 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.34%
|
445,187
|
$253,801 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.11%
|
147,638
|
$84,168 | — | 31 Mar 2025 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
0.11%
|
140,573
|
$80,141 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
117,875
|
$67,201 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
83,178
|
$47,412 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
60,809
|
$34,667 | — | 31 Mar 2025 | |
| Jason Bradley Terrell MD |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
33,192
|
$27,550 | — | 03 Aug 2022 | |
| Richard Brudnick |
3/4/5
|
Director |
—
class O/S missing
|
27,936
|
$23,187 | — | 12 Jan 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
32,270
|
$18,397 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
30,596
|
$17,443 | — | 31 Mar 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
21,482
|
$12,247 | — | 31 Mar 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.01%
|
17,713
|
$9,202 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
12,663
|
$7,219 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
10,818
|
$6,167 | — | 31 Mar 2025 | |
| Creative Planning |
13F
|
Company |
0.01%
|
10,056
|
$5,733 | — | 31 Mar 2025 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0%
|
5,000
|
$2,851 | — | 31 Mar 2025 | |
| Founders Capital Management |
13F
|
Company |
0%
|
2,000
|
$1,140 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
900
|
$513 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
619
|
$353 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
300
|
$171 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
265
|
$151 | — | 31 Mar 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
200
|
$98 | — | 31 Mar 2025 |
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2025
As of 30 Jun 2025,
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,985,160 shares.
The largest 10 holders included
Lagoda Investment Management, L.P., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Silverberg Bernstein Capital Management LLC, CITADEL ADVISORS LLC, STATE STREET CORP, NORTHERN TRUST CORP, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
24
Q2 2025 holders
28
Holder diff
4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.